SCHEMBL2300977

SCHEMBL2300977

Clc1ccc(OC2C[N]C2)cc1Cl

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.62
SLC6A3 Q01959 2/20 0.62
SLC6A2 P23975 1/20 0.62
FPR2 P25090 2/20 0.41
PROKR1 Q8TCW9 2/20 0.41
HSP90AA1 P07900 1/20 0.39
TP53 P04637 1/20 0.38
HRH1 P35367 7/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HAO1 Q9UJM8 1/20 0.38
CCR3 P51677 6/20 0.37
KCNH2 Q12809 3/20 0.37
KDM4E B2RXH2 1/20 0.36
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2299212 0.84 SLC6A2 (0.45) SLC6A4SLC6A3SLC6A2FPR2PROKR1
SCHEMBL2300752 0.84 SLC6A4 (0.45) SLC6A4SLC6A3SLC6A2FPR2PROKR1
SCHEMBL2297195 0.84 SLC6A4 (0.45) SLC6A4SLC6A3SLC6A2KCNH2TSHR
SCHEMBL3113548 0.81 SLC6A4 (0.59) SLC6A4SLC6A3SLC6A2FPR2PROKR1
SCHEMBL2297229 0.80 PGR (0.54) SLC6A4SLC6A3SLC6A2
SCHEMBL2302743 0.78 SLC6A4 (0.52) SLC6A4SLC6A3SLC6A2FPR2PROKR1
SCHEMBL2301845 0.77 SLC6A4 (1.00) SLC6A4SLC6A3SLC6A2KCNH2
Hydrochloric Acid SCHEMBL5218770 0.76 SLC6A4 (0.96) SLC6A4SLC6A3SLC6A2KCNH2
Hydrochloric Acid SCHEMBL30357916 0.76 SLC6A4 (0.96) SLC6A4SLC6A3SLC6A2KCNH2
SCHEMBL2298742 0.76 SLC6A4 (0.57) SLC6A4SLC6A3SLC6A2FPR2PROKR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010022055-A2 INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS AMGEN INC. (US) 2010-02-25 WO claimed
EP-2536689-A1 ARYL CARBOXAMIDE DERIVATIVES AS SODIUM CHANNEL INHIBITORS FOR TREATMENT OF PAIN Amgen Inc. (US) 2012-12-26 EP disclosed
WO-2011103196-A1 ARYL CARBOXAMIDE DERIVATIVES AS SODIUM CHANNEL INHIBITORS FOR TREATMENT OF PAIN AMGEN INC. (US) 2011-08-25 WO disclosed
WO-2010022055-A2 INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS AMGEN INC. (US) 2010-02-25 WO disclosed